GSA Capital Partners’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,572
Closed -$129K 2060
2023
Q4
$129K Sell
20,572
-5,224
-20% -$39.9K 0.01% 1382
2023
Q3
$570K Sell
25,796
-14,555
-36% -$380K 0.05% 708
2023
Q2
$285K Buy
40,351
+39,482
+4,543% +$909K 0.03% 1080
2023
Q1
$40K Buy
869
+670
+337% +$73.1K ﹤0.01% 1409
2022
Q4
$28K Sell
199
-192
-49% -$39.4K ﹤0.01% 1383
2022
Q3
$221K Buy
+391
New +$257K 0.03% 1152
2021
Q4
Sell
-33
Closed -$152K 1894
2021
Q3
$152K Buy
+33
New +$166K 0.02% 1284
2021
Q1
Sell
-32
Closed -$196K 1582
2020
Q4
$196K Buy
+32
New +$196K 0.03% 998
2020
Q3
Sell
-5
Closed -$33K 1428
2020
Q2
$33K Sell
5
-70
-93% -$297K 0.02% 548
2020
Q1
$242K Buy
+75
New +$312K 0.06% 633
2018
Q4
Sell
-7
Closed -$242K 1823
2018
Q3
$242K Buy
+7
New +$231K 0.01% 1417

Other funds holding TTOO

GSA Capital Partners's TTOO Position: Q1 2024 in Review

GSA Capital Partners sold out of T2 Biosystems, Inc (TTOO) in Q1 2024, closing a stake of 20,572 shares — an estimated $129K sold.

GSA Capital Partners first reported a position in TTOO in Q3 2018 and held it in 11 quarters. The position peaked at $570K in Q3 2023. 19 funds tracked by Wall St. Rank hold TTOO as of Q1 2024.

  • GSA Capital Partners reported no remaining T2 Biosystems, Inc position as of Q1 2024 after selling out during the quarter.
  • GSA Capital Partners sold 20,572 T2 Biosystems, Inc shares in Q1 2024, an estimated $129K.
  • GSA Capital Partners first reported a position in T2 Biosystems, Inc in Q3 2018 and held it in 11 quarters.
  • GSA Capital Partners's T2 Biosystems, Inc position peaked at $570K in Q3 2023.
  • 19 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2024.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.